Terms: = Lung cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
246 results:
1. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1.
Xu T; Yin F; Shi K
Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
[TBL] [Abstract] [Full Text] [Related]
2. Social Determinants of Health and the Link to Colorectal cancer Outcomes.
Lorentsen MK; Sanoff HK
Curr Treat Options Oncol; 2024 Apr; 25(4):453-464. PubMed ID: 38498252
[TBL] [Abstract] [Full Text] [Related]
3. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
4. An International Survey of Practices in the Investigation and Endoscopic treatment of Peripheral Pulmonary Lesions amongst Interventional Bronchoscopists.
Soumagne T; Dutau H; Eapen G; Guibert N; Hergott C; Maldonado F; Saka H; Fortin M
Respiration; 2024; 103(3):146-154. PubMed ID: 38402862
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
Fan C; Jiang Z; Teng C; Song X; Li L; Shen W; Jiang Q; Huang D; Lv Y; Du L; Wang G; Hu Y; Man S; Zhang Z; Gao N; Wang F; Shi T; Xin T
ESMO Open; 2024 Apr; 9(4):102384. PubMed ID: 38377785
[TBL] [Abstract] [Full Text] [Related]
6. Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients.
Carrillo-García J; Lacerenza S; Hindi N; Moura DS; Marquina G; Parra Corral D; Olalla J; María Cano Cano J; Hoyos S; Renshaw M; Mondaza-Hernández JL; Di Lernia D; Casado A; Manzano A; Gutierrez A; Martin-Broto J
Cytokine; 2024 May; 177():156542. PubMed ID: 38364458
[TBL] [Abstract] [Full Text] [Related]
7. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Qu J; Zhang T; Zhang X; Zhang W; Li Y; Gong Q; Yao L; Lui S
Clin Radiol; 2024 Apr; 79(4):e582-e591. PubMed ID: 38310058
[TBL] [Abstract] [Full Text] [Related]
8. Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation.
Ma C; Zhang X; Mo X; Yu Y; Xiao Z; Wu J; Ding L; Lei C; Zhu Y; Zhang H
Phytomedicine; 2024 Mar; 125():155351. PubMed ID: 38232540
[TBL] [Abstract] [Full Text] [Related]
9. Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway.
Li P; Sun Q; Bai S; Wang H; Zhao L
Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38186308
[TBL] [Abstract] [Full Text] [Related]
10. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
11. OTU deubiquitinase 7B facilitates the hyperthermia-induced inhibition of lung cancer progression through enhancing Smac-mediated mitochondrial dysfunction.
Sun C; Bai J; Sun J; Sun Y; Zhang F; Li H; Liu Y; Meng L; Wang X
Environ Toxicol; 2024 Apr; 39(4):1989-2005. PubMed ID: 38088504
[TBL] [Abstract] [Full Text] [Related]
12. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract] [Full Text] [Related]
13. Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
Hong Y; Miao Q; Zheng X; Xu Y; Huang Y; Chen S; Huang Z; Xu H; Jiang K; Zhong Q; Zhang L; Zheng X; Zeng H; Yang S; Li Y; Li S; Zhuang W; Lin G
J Neurooncol; 2023 Nov; 165(2):301-312. PubMed ID: 37995007
[TBL] [Abstract] [Full Text] [Related]
14. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
[TBL] [Abstract] [Full Text] [Related]
15. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
[TBL] [Abstract] [Full Text] [Related]
16. Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer.
Honkanen TJ; Luukkainen MEK; Koivunen JP
Cancer Biol Ther; 2023 Dec; 24(1):2256906. PubMed ID: 37722715
[TBL] [Abstract] [Full Text] [Related]
17. "
Campaña C; Cabieses B; Obach A; Vezzani F
Front Public Health; 2023; 11():1228304. PubMed ID: 37663832
[TBL] [Abstract] [Full Text] [Related]
18. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer.
Xie X; Laster KV; Li J; Nie W; Yi YW; Liu K; Seong YS; Dong Z; Kim DJ
Cell Mol Life Sci; 2023 Aug; 80(9):272. PubMed ID: 37646890
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.
Nakahama K; Izumi M; Yoshimoto N; Fukui M; Sugimoto A; Nagamine H; Ogawa K; Sawa K; Tani Y; Kaneda H; Mitsuoka S; Watanabe T; Asai K; Kawaguchi T
Cancer Chemother Pharmacol; 2023 Nov; 92(5):381-390. PubMed ID: 37606723
[TBL] [Abstract] [Full Text] [Related]
20. TRIM11 promotes cell proliferation of non-small cell lung cancer through the inhibition of ferroptosis by AMPK.
Liang Z; Li J; Zhang G; Chen M
Clin Respir J; 2023 Oct; 17(10):1006-1016. PubMed ID: 37604203
[TBL] [Abstract] [Full Text] [Related]
[Next]
